Note down the history in detail, medication use that may trigger anxiety, and the presence of risk factors associated with geriatric anxiety.
| Lifestyle changes | Sleep, diet, exercise, socialization |
| Behaviour therapy | Relaxation therapy, systemic desensitisation, exposure and response prevention |
| Cognitive therapy | Cognitive behaviour therapy |
| Mindfulness | Focusing on the "now" |
| Miscellaneous | Yoga, art therapy, dance therapy, music therapy, cognitive rehabilitation, social activities/networking, alternative therapies |
| SSRI | Escitalopram, Sertraline |
| SNRI | Venlafaxine, Desvenlafaxine, Duloxetine |
| Others | Mirtazapine, Pregabalin, Tianeptine, Buspirone |
| TCA | Nortriptyline |
Clinical practice guidelines can help streamline the process of diagnosis and treatment for geriatric anxiety disorder.
GAD: Generalised Anxiety Disorder; OCD: Obsessive compulsive disorder; SNRI: Serotonin-norepinephrine reuptake inhibitor; SSRI: Selective serotonin reuptake inhibitor; TCA: Tricyclic antidepressant.
Subramanyam AA, Kedare J, Singh OP, et al. Clinical practice guidelines for Geriatric Anxiety Disorders. Indian J Psychiatry. 2018;60(Suppl 3):S371-S382.
Dar SA, Bhat BA, Jan MM. Addition of benzodiazepines to selective serotonin reuptake inhibitors to optimize treatment of depression: a hospital based study. Int J Res Med Sci. 2018;6(6):2081-5.
Chattopadhyay K, Singh AP. Anxiety and its impact on quality of life among urban elderly population in India: An exploratory study. Indian J Res Homoeopathy. 2016;10:133-41.
Melaragno AJ. Pharmacotherapy for anxiety disorders: from first-line options to treatment resistance. Focus. 2021;19(2):145-60.
A 34-year-old female patient presented with symptoms of anxiety. The patient had a 10-month history of anxiety symptoms.
A 38-year-old male patient presented with symptoms of anxiety and comorbid depression.
Anxiety disorders, characterised primarily by intense and exaggerated anxiety without real threats, are frequently encountered in the general population.
Anxiety disorders (ADs) have a significant impact on individuals' quality of life and productivity, contributing to substantial economic losses at the national level.